United Therapeutics (UTHR) Work In Process (2010 - 2020)

United Therapeutics (UTHR) has 11 years of Work In Process data on file, last reported at $28.1 million in Q1 2020.

• For the quarter ending Q1 2020, Work In Process rose 6.84% year-over-year to $28.1 million; the trailing twelve-month figure through Mar 2020 stood at $28.1 million (up 6.84% YoY), and the FY2019 full-year result was $29.1 million, up 3.93% from the prior year.
• Work In Process slipped to $28.1 million in Q1 2020, from $29.1 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $29.8 million in Q3 2019 to a low of $22.9 million in Q1 2017.
• A 5-year average of $26.2 million and a median of $26.2 million in 2016 frame the typical range for Work In Process.
• Across the five-year window, Work In Process increased 21.29% in 2016 and declined 13.33% in 2017, its largest moves.
• Tracing UTHR's Work In Process over 5 years: stood at $24.9 million in 2016, then slipped by 3.21% to $24.1 million in 2017, then advanced by 16.18% to $28.0 million in 2018, then advanced by 3.93% to $29.1 million in 2019, then retreated by 3.44% to $28.1 million in 2020.
• Business Quant data shows UTHR's Work In Process at $28.1 million in Q1 2020, $29.1 million in Q4 2019, and $29.8 million in Q3 2019.